Summary
The expression of specific T-cell receptor gene segments by T lymphocytes appears to be critically important for the induction of several experimental autoimmune diseases mediated by these cells. We examined whether this situation also applied to non-obese diabetic mice by using various T-cell receptor VΒ-specific monoclonal antibodies. No significant age- or sex-related differences were observed in VΒ usage by peripheral and splenic T lymphocytes. CD8+ T lymphocytes among the islet-derived mononuclear cells isolated from 20-week-old female non-obese diabetic mice showed heterogeneity of their VΒ gene usage. In order to examine the role of T lymphocyte subsets expressing specific T-cell receptor VΒ gene segments in the development of diabetes mellitus, T-cell receptor VΒ-specific monoclonal antibodies were administered to 10-week-old male non-obese diabetic mice treated with cyclophosphamide. None of the antibodies used could significantly diminish the incidence of cyclophosphamide-induced diabetes and the severity of insulitis [anti-VΒ3 (11 of 22 mice became diabetic, 50%), anti-VΒ5 (9 of 14, 64%), anti-VΒ8 (9 of 21, 43%), anti-VΒ11 (12 of 23, 52%), anti-VΒ14 (7 of 12, 58%), and anti-VΒ5 + anti-VΒ11 (6 of 12, 50%)] when compared with control mice (12 of 21, 57%). In addition, there were no significant differences in T-cell receptor VΒ usage between diabetic and non-diabetic cyclophosphamide-treated mice. These results suggest that five T-lymphocyte subsets expressing different T-cell receptor VΒ gene segments, considered to be candidates involved in the pathogenesis of autoimmune diabetes, do not individually contribute to the development of cyclophosphamide-induced diabetes in non-obese diabetic mice.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Makino S, Kunimoto K, Muraoka Y et al. (1980) Breeding of a non-obese, diabetic strain of mice. Exp Anim (Tokyo) 29: 1–13
Ogawa M, Maruyama T, Hasegawa T et al. (1985) The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetic (NOD) mice. Biomed Res 6: 103–105
Harada M, Makino S (1986) Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy1.2 antibody. Exp Anim 35: 501–504
Makino S, Harada M, Kishimoto Y, Hayashi Y (1986) Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background. Exp Anim 35: 495–498
Bendelac A, Carnaud C, Boitard C, Bach JF (1987) Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt2+ T cells. J Exp Med 166: 823–832
Miller BJ, Appel MC, O'Neil JJ (1988) Both the Lyt2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 140: 52–58
Koike T, Itoh Y, Ishii T et al. (1987) Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes 36: 539–541
Charlton B, Mandel TE (1988) Progression from insulitis to Β-cell destruction in NOD mouse requires L3T4+ T-lymphocytes. Diabetes 37: 1108–1112
Charlton B, Bacelj A, Mandel TE (1988) Administration of silica particles or anti-Lyt2 antibody prevents Β-cell destruction in NOD mice given cyclophosphamide. Diabetes 37: 930–935
Nagata M, Yokono K, Hayakawa M et al. (1989) Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice. J Immunol 143: 1155–1162
Taki T, Nagata M, Ogawa W et al. (1991) Prevention of cyclophosphamide-induced and spontaneous diabetes in NOD/Shi/Kbe mice by anti-MHC class I Kd monoclonal antibody. Diabetes 40: 1203–1209
Hayakawa M, Yokono K, Nagata M et al. (1991) Morphological analysis of selective destruction of pancreatic Β-cells by cytotoxic T-lymphocytes in NOD mice. Diabetes 40: 1210–1217
Urban JL, Kumar VK, Kono DH et al. (1988) Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibility for antibody therapy. Cell 54: 577–592
Acha-Orbea H, Mitchell DJ, Timmermann L et al. (1988) Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific intervention. Cell 54: 263–273
Zaller DM, Osman G, Kanagawa O, Hood L (1990) Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor VΒ-specific antibodies. J Exp Med 171: 1943–1955
Hatamori N, Yokono K, Nagata M, Shii K, Baba S (1990) Impaired mitogen-induced expression of high-affinity interleukin 2 receptors on spleen cells from NOD/Shi/Kbe mice. Diabetes 39: 1070–1078
Pullen AM, Marrack P, Kappler JW (1988) The T-cell repertoire is heavily influenced by tolerance of polymorphic self-antigens. Nature 335: 796–801
Payne J, Huber BT, Cannon NA et al. (1988) Two monoclonal rat antibodies with specificity of the Β-chain variable region VΒ6 of the murine T-cell receptor. Proc Natl Acad Sci USA 85: 7695–7698
Okada CY, Holzmann B, Guidos C, Palmer E, Weissman IL (1990) Characterization of a rat monoclonal antibody specific for a determinant encoded by the VΒ7 gene segment. J Immunol 144: 3473–3477
Staerz U, Rammensee HG, Benedetto J, Bevan M (1985) Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. J Immunol 134: 3994–4000
Tomonari K, Lovering E (1988) T-cell receptor-specific monoclonal antibodies against a VΒ11-positive mouse T-cell clone. Immunogenetics 28: 445–451
Kappler J, Roehm N, Marrack P (1987) T cell tolerance by clonal elimination in the thymus. Cell 49: 273–280
Bill J, Appel VB, Palmer E (1988) An analysis of T-cell receptor variable region gene expression in major histocompatibility complex disparate mice. Proc Natl Acad Sci USA 85: 9184–9188
Bill J, Kanagawa O, Woodland RL, Palmer E (1989) The MHC molecule I-E is necessary but not sufficient for the clonal deletion of VΒ11-bearing T cells. J Exp Med 169: 1405–1419
Vacchio MS, Hodes RJ (1989) Selective decreases in T cell receptor VΒ expression. Decreased expression of specific VΒ families is associated with expression of multiple MHC and non-MHC gene products. J Exp Med 170: 1335–1341
Nishimoto H, Kikutani H, Yamamura K, Kishimoto T (1987) Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature (Lond) 328: 432–434
Lund T, O'Reilly L, Hutchings P et al. (1990) Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes-encoding modified I-A Β-chain or normal I-E α-chain. Nature (Lond) 345: 727–729
Reich E, Sherwin RS, Kanagawa O, Janeway CA Jr (1989) An explanation for the protective effect of the MHC class II I-E-molecule in murine diabetes. Nature 341: 326–328
Reich E, Sherwin RS, Kanagawa O, Janeway CA Jr (1991) An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes (Correction). Nature 352: 88
Bacelj A, Charlton B, Mandel TE (1989) Prevention of cyclophosphamide-induced diabetes by anti-VΒ8 T-lymphocyte-receptor monoclonal antibody therapy in NOD/Wehi mice. Diabetes 38: 1492–1495
Nakano N, Kikutani H, Nishimoto H, Kishimoto T (1991) T cell receptor V gene usage of islet Β cell-reactive T cells is not restricted in non-obese diabetic mice. J Exp Med 173: 1091–1097
Lipes MA, Rosenzweig A, Seidman JG (1990) A challenge to the I-E “VΒ hypothesis” in the NOD mouse (Abstract). Diabetes 39: 68 A (Abstract)
Lipes MA, Eisenbarth GS (1990) Transgenic mouse models of type I diabetes. Diabetes 39: 874–884
McDuffie M, Schweiger D, Reitz B, Ostrowska A, Knight AM, Dyson PJ (1992) I-E dependent deletion of VΒ17a+ T cells by Mtv-3 from the nonobese diabetic mouse. J Immunol 148: 2097–2102
Harada M, Makino S (1984) Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia 27: 604–606
O'Reilly LA, Hutchings PR, Crocker PR et al. (1991) Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression. Eur J Immunol 21: 1171–1180
Charlton B, Bacelj A, Slattery RM, Mandel TE (1989) Cyclophosphamide-induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes 38: 441–447
Shizuru JA, Taylor-Edwards C, Livingstone A, Fathman CG (1991) Genetic dissociation of T cell receptor VΒ gene requirements for spontaneous murine diabetes. J Exp Med 174: 633–638
McDuffie M (1991) Diabetes in NOD mice does not require T lymphocytes expressing VΒ8 or VΒ5. Diabetes 30: 1555–1559
Candeias S, Katz J, Benoist C, Mathis D, Haskins K (1991) Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors. Proc Natl Acad Sci USA 88: 6167–6170
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taki, T., Yokono, K., Amano, K. et al. Effect of T-cell receptor VΒ-specific monoclonal antibodies on cyclophosphamide-induced diabetes mellitus in non-obese diabetic mice. Diabetologia 36, 391–396 (1993). https://doi.org/10.1007/BF00402273
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00402273